Summary by Moomoo AI
DONG SUNSHINE CHANGJIANG PHARMACEUTICALS (HEC CJ PHARM) ANNOUNCED ON 21 MARCH 2024 THAT DURING ITS PRIVATISATION TRANSACTION, EXECUTIVES RECEIVED TRANSACTION DISCLOSURES PURSUANT TO RULE 22 OF THE HONG KONG CODE ON ACQUISITIONS AND MERGERS. The disclosure shows that CICC Financial Trading Limited completed the liquidation of two derivatives contracts on March 20, 2024, involving 240,000 shares each, with a contract expiration date of March 22, 2025. The reference price of the first contract is $10.7184 per share for a total amount of $2,572,418.93; the reference price of the second contract is $10.7472 per share for a total amount of $2,579,318.28. After the transaction, the number of shares held by CICC Financial Trading Limited is 601,800 shares. CICC Financial Trading Limited is the partner of the Contracting Party and the transaction is conducted on its own account.